Angiotensin II and transforming growth factor β affect cardiovascular and renal disease in patients with type 2 diabetes mellitus: benefits of dpp-4 inhibitors treatment

par Teona A. Shvangiradze, Irina Z. Bondarenko, Ekaterina A. Troshina, Marina V. Shestakova, Larisa V. Nikankina, Natalia S. Fedorova
Publié 2019-12-01

TGF-β and FRF-21: association with coronary artery disease in patients with type 2 diabetes and obesity

par Teona A. Shvangiradze, Irina Z. Bondarenko, Ekaterina A. Troshina, Larisa V. Nikankina, Svetlana S. Kukharenko, Marina V. Shestakova
Publié 2017-11-01

Profile of microRNAs associated with coronary heart disease in patients with type 2 diabetes

par Teona A Shvangiradze, Irina Z Bondarenko, Ekaterina A Troshina, Marina V Shestakova, Alexander V Ilyin, Larisa V Nikankina, Aleksandr V Karpukhin, Tat'yana A Muzaffarova, Fatimat M Kipkeeva, Kristina A Grishina, Anna Yu Kuzevanova
Publié 2016-12-01

Russian national clinical recommendations for morbid obesity treatment in adults. 3rd revision (Morbid obesity treatment in adults)

par Ivan I. Dedov, Galina A. Mel'nichenko, Marina V. Shestakova, Ekaterina A. Troshina, Natalya V. Mazurina, Ekaterina A. Shestakova, Yuriy I. Yashkov, Alexander E. Neimark, Elena V. Biryukova, Irina Z. Bondarenko, Natalia S. Bordan, Fatima H. Dzgoeva, Ekaterina V. Ershova, Kseniya A. Komshilova, Ashot M. Mkrtumyan, Nina A. Petunina, Tatiana I. Romantsova, Elena G. Starostina, Leonid G. Strongin, Ludmila A. Suplotova, Valentin V. Fadeyev
Publié 2018-04-01